Contact Us
|
Sitemap
|
Home
History & Overview
Learn More
A Better Way and Why
Key Management
Professional Affiliations
Customer List
FAQ
Job Opportunities
Contact Us
Press Releases
Events
Literature
References
Glossary
Express Assays
Custom Assays
BCS Services
Transporters
Preclinical PK
Bioanalytical Services
Formulation Assessment
Absorption
Distribution
Metabolism
Excretion/Toxicology
Physicochemical
CellPort Technologies™
CellPort Pgp
My Documents
My Downloads
Customer Contacts
Change My Information
Document Details
Add New Document
News & Literature
Press Releases
Events
Literature
References
Glossary
Literature
View By Type
View By Process
View By Model
View Other Materials
Case Study
CS100 -
In vitro studies, the FDA-endorsed shortcut
CS101 -
Safety First and Fast
CS102 -
Increasing Specificity in Transporter Assays
Essential ADME
EA101 -
Solubility Determined by Shake-Flask Assay Data Sheet
EA102 -
LogD by Shake-Flask Assay Data Sheet
EA103 -
pKa, LogP, and LogD By Potentiometric Titration Assay Data Sheet
EA104 -
Express Solubility Assay Data Sheet
EA105 -
Express LogD by Shake-Flask Assay Data Sheet
EA150 -
Stability in Gastric Fluids Assay Data Sheet
EA151 -
Stability in Plasma Assay Data Sheet
EA181 -
Cell Cytotoxicity Assay Data Sheet
EA182 -
Hepatocyte Cytotoxicity Assay Data Sheet
EA190 -
Hemolysis
EA201 -
Express Unidirectional Permeability Through Caco-2 Monolayers Assay Data Sheet
EA201r -
Example of a Basic Report Unidirectional Caco-2
EA202 -
Express Bidirectional Permeability Through Caco-2 Monolayers Assay Data Sheet
EA202r -
Example of a Basic Report Bidirectional Caco-2 assay
EA203 -
Express MDR1-MDCK for BBB Penetration Potential Assay Data Sheet
EA204 -
Express P-gp Substrate Assessment Determined Using MDR1-MDCK Cell Monolayers Assay Data Sheet
EA205 -
Unidirectional Permeability Through Intestinal Tissue Assay Data Sheet
EA206 -
Bidirectional Permeability Through Intestinal Tissue Assay Data Sheet
EA207 -
Unidirectional Permeability Through Porcine Buccal Epithelium Assay Data Sheet
EA208 -
Unidirectional Permeability Through Porcine Nasal Epithelium Assay Data Sheet
EA209 -
Unidirectional Permeability Through Excised Skin Assay Data Sheet
EA211 -
Unidirectional Permeability Through Caco-2 Cell Monolayers Assay Data Sheet
EA212 -
Bidirectional Permeability Through Caco-2 Cell Monolayers Assay Data Sheet
EA212r -
Example of a Standard Report for a Bidirectional Caco-2 Assay
EA218 -
Human P-gp Substrate Assessment Across MDR1-MDCK Cell Monolayers
EA219 -
P-gp Inhibitor Assessment Across Cell Monolayers
EA250 -
Express P-gp Substrate Assessment in CellPort CPT-B1 BCRP Knockdown Cells
EA251 -
Express BCRP Substrate Assessment in CPT-B1 BCRP Knockdown Cells
EA401 -
Express Metabolic Stability (human liver microsomes) Assay Data Sheet
EA402 -
Express Metabolic Stability (rat liver microsomes) Assay Data Sheet
EA403 -
Metabolic Stability in Liver Microsomes Assay Data Sheet
EA403r -
Example of a Standard Report for a Metabolic Stability Assay
EA404 -
Metabolic Stability in the Presence of S9 Fractions Assay Data Sheet
EA405 -
Metabolic Stability in the Presence of Hepatocytes Assay Data Sheet
EA406 -
IC50 Determination Using Fluorogenic Substrates Assay Data Sheet
EA407 -
CYP Inhibition Screen in Human Liver Microsomes Using LC-MS-MS Assay Data Sheet
EA408 -
CYP 450 Phenotyping Using Supersomes Assay Data Sheet
EA409 -
Induction of CYP1A2, 2C9, and 3A4 in Human Hepatocytes Assay Data Sheet
EA410 -
Ki Determination in Human Liver Microsomes Using LC-MS-MS Assay Data Sheet
EA411 -
Metabolic Stability in Human Intestinal Microsomes Assay Data Sheet
EA412 -
Metabolite Identification (Microsomal or S9) Assay Data Sheet
EA413 -
CYP Inhibition IC50 Using LC-MS-MS in Human Liver Microsomes
EA414 -
Mechanism-based CYP Inhibition Using LC-MS-MS in Human Liver Microsomes
EA470r -
Example of a Basic Report for Metabolism and Protein Binding Assays
EA701 -
Express Plasma Protein Binding (human plasma) Assay Data Sheet
EA702 -
Express Plasma Protein Binding (rat plasma) Assay Data Sheet
EA703 -
Plasma Protein Binding Using Ultracentrifugation Assay Data Sheet
EA703r -
Example of a Standard Report for a Human Plasma Protein Binding Assay
EA704 -
Plasma Protein Binding Using Equilibrium Dialysis Assay Data Sheet
EA705 -
Plasma Protein Binding Using Ultrafiltration Assay Data Sheet
EA707 -
Express Fraction Unbound (rat brain)
EA801 -
Relative Bioavailability in Rats Assay Data Sheet
EA802 -
Test Compound Brain to Plasma Ratio in Rat Assay Data Sheet
EA803 -
Rat Brain Perfusion Assay Data Sheet
EA804 -
Absolute Bioavailability in Mice Assay Data Sheet
EA805 -
Bioavailability in Dogs Assay Data Sheet
EA807 -
Express Bioavailability-Exposure in Mice Assay Data Sheet
EA808 -
Express Bioavailability-Exposure in Rats Assay Data Sheet
EA810 -
Express Bioavailability-Exposure in Dogs Assay Data Sheet
EA811 -
Rat Carotid Infusion
EA812 -
Express Bioavailability-Exposure in Dogs Non-crossover
EA901 -
Preliminary BCS Solubility Classification by Shake Flask Assay Data Sheet
EA902 -
GLP BCS Solubility Classification by Shake Flask Assay Data Sheet
EA903 -
Preliminary BCS Permeability Classification Using Caco-2 Cell Monolayers Assay Data Sheet
EA904 -
GLP BCS Permeability Classification Using Caco-2 Cell Monolayers Assay Data Sheet
Overview Sheet
OS001 -
FDA Drug Interaction Guidance Sept 2006
OS010 -
Index of Assays and Services
OS011 -
Specialized ADME Assessment
OS021 -
ADME Express In Vitro Sales Order and Sample Submittal form
OS022 -
ADME Express In Vivo Sales Order and Sample Submittal form
OS109 -
Formulation Assessment Primer
OS200b -
Overview of Absorption Systems' Blood-brain Barrier Models
OS400b -
Overview of Absorption Systems' Rat Biliary Excretion Model
OS600a -
Overview of Absorption Systems' Bioanalytical Services
Poster Presentation
PP1 -
Functional Evidence of Multiple Efflux Transport Systems in Caco-2 Cell Model
PP2 -
Utility of the Pgp Knockout Mouse In Situ Brain Perfusion to Determine the Brain Penetration Potential of Pgp Substrate Drugs
PP3 -
Silencing of Breast Cancer Resistance Protein Expression by Lentiviral shRNA transduction particles in Caco-2 models
PP4 -
Metabolizing_Activities_in_Rabbit_Cornea_and_Conjunctiva
PP5 -
Evaluation of a New Proprietary GRAS Formulation for Oral and Intravenous Administration
PP6 -
Functional Characterization of the MRP2 Transporter Using the Isolated Rat Liver Perfusion Model
PP7 -
Silencing of Breast Cancer Resistance Protein (BCRP) Expression and Function in Caco-2 Cells Using Lentiviral shRNA-mediated RNA Interference
PP8 -
Functional characterization of RNAi induced BCRP knockdown Caco-2 cells
PP9 -
Evaluation of the effect of 4-aromatic substitution on metabolic stability and metabolite profiles of 2AT using in vitro and ex-vivo models
PP10 -
Silencing of Multidrug Resistance-associated Protein 2 (MRP-2) Expression and Function in Caco-2 cells using Lentiviral shRNA
PP11 -
Pharmacokinetic Evaluation of Tizanidine Oral Spray in Male Beagle Dogs: Presented by Novadel
PP12 -
Characterization of Excised Rabbit Cornea and Conjunctiva as In Vitro Models for Ocular Drug Absorption Studies
PP13 -
Differentiation of Reversible and Mechanism-Based Inhibitors of Human CYP Mediated-Reactions by an IC50 Shift Approach
PP14 -
Hydrolysis of Latanoprost in Rabbit Ocular Tissues
PP15 -
Investigation of transporters involved in biliary clearance of drugs in the human liver using Caco-2 cells with stable MDR1 and MRP2 knockdown by shRNA: Presented by AstraZeneca
PP16 -
A comparison of the in vitro hydrolysis of Oseltamivir in matrices from various species
Research Report
RR1 -
Induction of CYP 1A and 3A4 Human Hepatocytes
RR2 -
New Assay for Determining the Barriers to Bioavailability
RR3 -
Induction of Cytochrome P450- 2C9- 2C19 and 2B6 Activities in Cryopreserve Human Hepatocytes
RR6 -
Establishment of an Intraduodenal Fistula Dog Model for Biopharmaceutics Studies
RR7 -
Intestinal Access Port Dog Model for Gastrointestinal Site for Drug Absorption
RR9 -
Identification of Cytochrome P450 Isoforms Responsible for Canadine Metabolism Using Human Supersomes
RR10 -
Ocular Summary Report
RR11 -
Superior Pgp Assay System
RR13 -
Evaluation of the MDR-MDCK cell line as a permeability screen for the blood brain barrier
© 1999-
2008
Absorption Systems LP
|
Legal Notice
|
Privacy Statement